EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

HemaSphere

ISSN 2572-9241 · Wiley

Neueste Artikel

  1. Emergency hematopoiesis in sepsis: A pathway to myeloid clonal expansion

    Olisaemeka Ogbue, Tariq Kewan, Serhan Unlu, Kartik Lakhotiya, Omar Mehkri, Rayna Ellison, Francois Fadell, Felipe de Almeida Sartori, Asfand Yar Cheema, Mark Orland, Arda Durmaz, Zachary Brady, Jennifer VanOudenhove, Abhay Singh, Valeria Visconte, Lourdes Mendez, David S. Bosler, Stephanie Halene, Mohammed J. Al‐Jaghbeer, Abhijit Duggal, Jaroslaw P. Maciejewski, Carmelo Gurnari

    Erschienen: 2026-11DOI: 10.1002/hem3.70495

  2. Improved multistate survival in younger AML patients over time

    Sjoerd J. F. Hermans, Jurjen Versluis, Gert J. Ossenkoppele, Edo Vellenga, Thomas Pabst, Leo F. Verdonck, Johan Maertens, Dimitri Breems, Markus G. Manz, Bart Biemond, Jürgen Kuball, Marinus van Marwijk Kooy, Mojca Jongen‐Lavrencic, Peter C. Huijgens, Jakob Passweg, Bjørn T. Gjertsen, Soren Lehmann, Patrycja Gradowska, Berna Beverloo, Peter Valk, Gerwin Huls, Liesbeth C. de Wreede, Bob Löwenberg, Jan J. Cornelissen

    Erschienen: 2026-11DOI: 10.1002/hem3.70503

  3. Management of advanced mycosis fungoides and Sézary Syndrome: International Recommendations for systemic treatments and allogeneic hematopoietic cell transplantation from the European Hematology Association, the EORTC Cutaneous Lymphoma Tumours Group, the International Society for Cutaneous Lymphoma, and the Lymphoma Working Party of the EBMT

    Francesco Onida, Pietro Quaglino, Julia Scarisbrick, Anna Sureda, Emmilia Hodak, Evangelia Papadavid, Silvia Alberti‐Violetti, Martine Bagot, Lorenzo Cerroni, Amrita Goyal‐O'Leary, Rudolf Stadler, Rein Willemze, Jasmine Zain, Marco Ardigò, Emilio Berti, Adèle de Masson, Rafael F. Duarte, Francine Foss, Eva González‐Barca, Joan Guitart, Pablo Ortiz‐Romero, Alessandro Pileri, Pierluigi Porcu, Henry M. Prince, Sima Rozati, Serena Rupoli, Maarten H. Vermeer, Sean Whittaker, Nicola Pimpinelli, Pier Luigi Zinzani

    Erschienen: 2026-11DOI: 10.1002/hem3.70505

  4. Sustained disease remission with reduced‐intensity allogeneic hematopoietic cell transplant for VEXAS syndrome

    Bhavisha A. Patel, Ajoy Dias, Daniele Avila, Tonya Jenkins, Lisa Duncan, Roxanne Merkel, Alice Fike, Julie Onyechi, Xingmin Feng, Fernanda Gutierrez‐Rodrigues, Ivana Darden, Shanni Liu, Benjamin Turturice, Jennifer Hendricks, Erin Flannelly, Kristen Cole, Kanak Parmar, Ruba Shalhoub, Colin O. Wu, Jennifer Lotter, Boeui Kang, Sachiko Kajigaya, Corina Gonzalez, Chuanfeng Wu, Marcela A. Ferrada, Jennifer Cuellar‐Rodriguez, Mary Czech, Katherine R. Calvo, Richard W. Childs, David B. Beck, Neal S. Young, Sung‐Yun Pai, Dennis D. Hickstein, Peter C. Grayson, Emma M. Groarke

    Erschienen: 2026-11DOI: 10.1002/hem3.70512

  5. Infections and their determinants in patients with non‐Hodgkin lymphoma receiving bispecific T‐cell antibodies: Results from an international multicenter cohort study

    Zainab Shahid, Michelle Okwali, Ashlee Joseph, David Nemirovsky, Derkach Andriy, Clare Grieve, Rafaella Tringale, Reid Merryman, Aaron Zou, Silvia Ferrari, Monica Rondi, Sean Harrop, Divya Somasekharannair, Jennifer Crombie, Gilles Salles, Giuseppe Gritti, Michael Dickinson, Lorenzo Falchi

    Erschienen: 2026-11DOI: 10.1002/hem3.70514

  6. Impact of venetoclax‐based therapies on CLL‐associated autoimmune cytopenias: A retrospective study conducted by ERIC

    Candida Vitale, Thomas Chatzikonstantinou, Christina Papangelou, Francesca Perutelli, Maria Chiara Montalbano, Giulia Bondielli, Elia Boccellato, Salem Alshemmari, Francesco Angotzi, Miguel Arguello‐Tomas, Tomas Arpas, Sandra Bašić‐Kinda, Sotiria Besikli‐Dimou, Łukasz Bołkun, Tomasz Buczek, Aleksandra Butrym, Katherine Chapis, Sofia Chatzileontiadou, Rosa Collado, Raul Cordoba Mascuñano, Lorenzo De Paoli, Marina Deodato, Maria Dimou, David Donaldson, Joanna Drozd‐Sokołowska, Salem Elias, Andrea Ferrario, Alberto Fresa, Anna Maria Frustaci, Rocío García‐Serra, Ajay Gogia, Isabel González‐Gascón‐y‐Marín, Vasko Graklanov, Maria Hryniewiecka, Zhu Huayuan, Elzbieta Iskierka‐Jażdżewska, Paula Jablonowska‐Babij, Ozren Jaksic, Elzbieta Kalicińska, Maria Kislova

    Erschienen: 2026-11DOI: 10.1002/hem3.70522

  7. Modulation of the RNA‐sensing RIG/MAVS pathway bypasses resistance to hypomethylating agents in acute myeloid leukemia

    Nadia El Khawanky, Tatiana Nedelko, Giada Mandracci, Yunus Barth, Yuan Jiang, Kai Wang, Marc Rosenbaum, Christin Weiß, Christoph Geisenberger, Stefan Enßle, Ana M. Gómez Martínez, Sascha Göttert, Noomen Hamed, Julius C. Fischer, Jürgen Ruland, Dirk H. Busch, Hendrik Poeck, Katharina S. Götze, Anna L. Illert, Florian Bassermann, Simon M. Heidegger

    Erschienen: 2026-11DOI: 10.1002/hem3.70523

  8. Chemoimmunotherapy‐associated CD20 ( MS4A1 ) resistance mutations in Waldenström macroglobulinemia: Epitope disruption independent of expression with implications for CD20‐directed cellular therapies

    Alberto Guijosa, Nickolas Tsakmaklis, Sirano Dhe‐Paganon, Filip Garbicz, Ruben Carrasco, John Hatcher, Andres Ramirez‐Gamero, Dominic Pizzarella, Amanda Kofides, Shirong Liu, Hao Sun, Xia Liu, María L. Guerrera, Andrew R. Branagan, Gottfried von Keudell, Shayna R. Sarosiek, Jorge J. Castillo, Zachary R. Hunter, Steven P. Treon

    Erschienen: 2026-10DOI: 10.1002/hem3.70468

  9. Longitudinal assessments of MRD in high‐risk newly diagnosed transplant‐ineligible multiple myeloma in the BENEFIT study (IFM2020‐05)

    Jill Corre, Jerome Lambert, Arthur Bobin, Salomon Manier, Aurore Perrot, Lionel Karlin, Murielle Roussel, Noemie Bigot, Omar Benbrahim, Olivier Allangba, Philippe Rey, Véronique Dorvaux, Marguerite Vignon, Virginie Roland, Réda Garidi, Jean‐Noel Bastie, Marie‐Lorraine Chretien, Sophie Godet, Lydia Montes, Brieuc Cherel, Anne Vekhoff, Thomas Chalopin, Borhane Slama, Kamel Laribi, Claire Dingremont, Christophe Roul, Valentine Richez‐Olivier, Clara Mariette, Sophie Rigaudeau, Claire Calmettes, Mamoun Dib, Mourad Tiab, Laure Vincent, Jacques Delaunay, Sabrina Maheo, Anais Schavgoulidze, Laurent Frenzel, Pascal Godmer, Ronan Le Calloch, Emilie Chalayer

    Erschienen: 2026-10DOI: 10.1002/hem3.70482

  10. A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist

    Binje Vick, Vindi Jurinovic, Kristina Kuhbandner, Lena Lagally, Lisa Latzko, Chiara Arnreich, Gerulf Hänel, Amelie Muth, Maximilian Schönung, Arnold Kloos, Maja Rothenberg‐Thurley, Annika M. Dufour, Stephanie Schneider, Lesca M. Holdt, Liliana Mura, Fabian Klein, Annette Frank, Dhruv Mehra, Annika Fröhlich, Johannes W. Bagnoli, Maya C. André, Claudia D. Baldus, Martin Carroll, Christine Dierks, Martin Ebinger, Katharina S. Götze, Pablo Menéndez, Christian Récher, Ambrine Sahal, Jean‐Emmanuel Sarry, Christian Thiede, Talía Velasco‐Hernández, Xiaoyan Wei, Jan H. Klusmann, Wolfgang Enard, Michael von Bergwelt‐Baildon, Wolfgang Hiddemann, Klaus H. Metzeler, Philipp A. Greif, Michael Heuser

    Erschienen: 2026-10DOI: 10.1002/hem3.70497

Jahrgänge

2026 · 2042025 · 2302024 · 1782023 · 2.9242022 · 2.7322021 · 1642020 · 1182019 · 2.5202018 · 2832017 · 17

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.